Expression of oncogenes during rat chemical hepatotumorigenesis promoted by estrogen.
To elucidate the role of oncogene expression in hepatocarcinogenesis, we examined the expression of 4 cellular oncogenes (c-myc, c-fos, Ha-ras and c-erbA) in liver tissues induced by chemical agents. Four groups of male Sprague-Dawley rats were examined in the present study. Rats of the first and second groups were given a single intraperitoneal injection of diethylnitrosamine (DEN), 200 mg/kg body weight. Two weeks later, these rats were divided into two groups; the DEN-C group received no further medication, whereas the DEN-DES group was given diethylstilbestrol (DES), 0.5 mg/day, for 12 months. The DEN group was given DEN, 100 ppm, in drinking water for five months as the hepatocellular carcinoma (HCC) group. The DES group was given DES, 0.5 mg/day, from the start for 8 months. Rats of the DEN-DES and DEN groups developed grossly visible hepatic tumors. Significantly higher levels of c-myc gene expression were observed in tissues of HCC of the DEN group and in neoplastic nodules of the DEN-DES groups than in the DES and DEN-C group. The increase of c-myc mRNA seemed to begin after 1 month of treatment and became significant at 4 months in the DEN-DES group. On the other hand, no significant differences in mRNA levels of c-fos, Ha-ras and c-erbA were observed among these four groups. Although the significance of increased c-myc gene expression in neoplastic liver is still not known, it is conceivable that the persistent elevation of c-myc gene expression in the DEN and DEN-DES groups might contribute to the development of rat chemical hepatotumorigenesis.
Himeno
Y
Y
Department of Internal Medicine, Faculty of Medicine, Kyoto University.
Fukuda
Y
Y
Hatanaka
M
M
Imura
H
H
D000818:Animals; D015342:DNA Probes; D004052:Diethylnitrosamine; D004054:Diethylstilbestrol / Q000633:toxicity*; D015972:Gene Expression Regulation, Neoplastic; D011905:Genes, ras / Q000187:drug effects*; D015151:Immunoblotting; D008099:Liver / Q000187:drug effects / Q000473:pathology*; D008114:Liver Neoplasms, Experimental / Q000235:genetics* / Q000473:pathology; D008297:Male; D011519:Proto-Oncogenes / Q000187:drug effects*; D012334:RNA, Neoplasm / Q000302:isolation & purification; D051381:Rats; D011919:Rats, Inbred Strains; D014158:Transcription, Genetic / Q000187:drug effects
D015342:DNA Probes; D012334:RNA, Neoplasm; D004052:Diethylnitrosamine; D004054:Diethylstilbestrol